Björn Glinghammar
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Hepatology top 5%
- Liver physiology and pathology
Papers in
-
- Peroxisome Proliferator-Activated Receptors 6
- Oncology 9
- Colorectal Cancer Screening and Detection 4
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Joseph Rafter (6 shared papers)Ewa Ehrenborg (5 shared papers)Ian A. Cotgreave (5 shared papers)Anders Hamsten (2 shared papers)Josefin Skogsberg (2 shared papers)Marco Venturi (1 shared paper)Jan Andersson (6 shared papers)Petra Thulin (7 shared papers)
- Journals
- International Journal of Molecular Medicine (4 papers)Biomarkers (3 papers)European Journal of Cancer Prevention (2 papers)Carcinogenesis (2 papers)Liver International (1 paper)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Björn Glinghammar
26 papers receiving 927 citations
Peers
Comparison fields: 5 of 93
- Pharmacology 217
- Hepatology 131
- Cancer Research 150
- Oncology 247
- Molecular Biology 417
Countries citing papers authored by Björn Glinghammar
This map shows the geographic impact of Björn Glinghammar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Glinghammar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Glinghammar more than expected).
Fields of papers citing papers by Björn Glinghammar
This network shows the impact of papers produced by Björn Glinghammar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Glinghammar. The network helps show where Björn Glinghammar may publish in the future.
Co-authors
The 25 scholars most cited alongside Björn Glinghammar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 107 | |
| 2 | 2013 | 89 | |
| 3 | 2007 | 81 | |
| 4 | 1997 | 70 | |
| 5 | 2003 | 65 | |
| 6 | 1999 | 61 | |
| 7 | 2001 | 59 | |
| 8 | 2014 | 57 | |
| 9 | 2008 | 51 | |
| 10 | 1999 | 43 | |
| 11 | 2009 | 39 | |
| 12 | 2007 | 35 | |
| 13 | 2000 | 34 | |
| 14 | 2006 | 30 | |
| 15 | 2016 | 26 | |
| 16 | 2003 | 25 | |
| 17 | 1999 | 20 | |
| 18 | 2012 | 19 | |
| 19 | 1998 | 14 | |
| 20 | 2008 | 11 |
About Björn Glinghammar
Björn Glinghammar is a scholar working on Molecular Biology, Oncology, Pharmacology, Pathology and Forensic Medicine and Epidemiology, having authored 27 papers that have together received 956 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers), Genetic factors in colorectal cancer (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Colorectal Cancer Screening and Detection (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Pharmacology (217 citations), Hepatology (131 citations), Cancer Research (150 citations), Oncology (247 citations) and Molecular Biology (417 citations). Björn Glinghammar has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Joseph Rafter, Ewa Ehrenborg, Ian A. Cotgreave, Anders Hamsten, Josefin Skogsberg, Marco Venturi, Jan Andersson, Petra Thulin, Ingalill Rafter and Heike Hellmold. Their work appears in journals such as International Journal of Molecular Medicine, Biomarkers, European Journal of Cancer Prevention, Carcinogenesis and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.